Position in OGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,425,620
-$3,275,971 QoQ
Shares Held
238,000
-63.7% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Derivatives in OGN
reported options exposure · as of Dec 31, 2025CallValue
$215,817
CallShares
30,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $681,590,231 across 11 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
1,437,685 | $181,637,122 | |
| 2 | GSK |
GSK plc
|
2,652,881 | $139,064,022 | |
| 3 | AZN |
Astrazeneca PLC
|
711,547 | $134,923,542 | |
| 4 | ABBV |
AbbVie Inc.
|
366,836 | $92,310,611 | |
| 5 | MRK |
Merck & Co., Inc.
|
380,081 | $48,840,408 | |
| 6 | SNY |
Sanofi
|
820,078 | $34,984,527 | |
| 7 | BIIB |
Biogen Inc.
|
88,149 | $19,045,472 | |
| 8 | NVS |
Novartis AG
|
106,157 | $16,636,925 |
All Filings in OGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,425,620 | 238,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,701,591 | 655,731 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $215,817 | 30,100 | Call | Defined | 2026-02-17 | |
| 2023-12-31 | $45,982,496 | 3,188,800 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $156,621 | 9,022 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $829,315 | 35,260 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||